Nigel Young - Chemring Group Insider

CMGMF -- USA Stock  

USD 2.22  0.00  0.00%

Interim CFO
Mr. Nigel Young was appointed as Senior NonExecutive Independent Director of Chemring Group PLC. Nigel Young became an independent nonexecutive director and Chairman of the Audit Committee on 1 May 2013, following his appointment as Interim Chief Financial Officer in August 2012. He was appointed as Senior Independent Director in March 2016. Nigels previous appointments include Finance Director of ALVIS PLC, First Technology PLC, Babcock International Group PLC and Morgan Advanced Materials Plc. Nigel has also undertaken a number of interim finance roles, including one at McBride Plc. He is currently a nonexecutive director and Chairman of P2i Limited, a provider of liquid repellent nanotechnology, and is a trustee and Board member of Orbis UK, a leading global eye charity.
Age: 62  CFO Since 2013      
(44) 1794 833955

Management Efficiency

The company has return on total asset (ROA) of 4.32 % which means that it generated profit of $4.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 4.23 % meaning that it generated $4.23 on every $100 dollars invested by stockholders.
The company has accumulated 158.13 M in total debt with debt to equity ratio (D/E) of 29.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemring Group plc has Current Ratio of 1.39 which is within standard range for the sector.

Similar Executives

Entity Summary

Michael Flowers, 54Chief Exec. Officer and Director383.00KN/AMr. Steve J. Bowers ACA , 42Group Fin. Director and Director820.00KN/AMs. Sarah L. Ellard FCIS, 44Group Legal Director, Company Sec., Exec. Director and Member of Risk Management CommitteeN/AN/AMr. Rik Armitage, Group Director of Strategy & TechnologyN/AN/AMr. Rupert Pittman, Group Director of Corporation Affairs and Member of Risk Management CommitteeN/AN/AChemring Group plc (CMGMF) is traded on OTC Market in USA. It is located in Roke Manor, Old Salisbury Lane, Romsey, Hampshire SO51 0ZN, United Kingdom and employs 3,000 people.

Chemring Group plc Leadership Team

Peter Hickson, Chairman
Andy Hamment, Director
Sarah Ellard, Director
CarlPeter Forster, Chairman
Ian Much, Director
Nigel Young, CFO
Steve Bowers, Director
Michael Flowers, CEO
Andrew Lewis, Director
Daniel Dayan, Director
Rupert Pittman, Director
Andrew Davies, Director

Stock Performance Indicators

Current Sentiment - CMGMF

Chemring Group plc Investor Sentiment
Macroaxis portfolio users are unresponsive in their opinion about investing in Chemring Group plc. What is your opinion about investing in Chemring Group plc? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Chemring Group and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.